ArticleJournal of developmental and behavioral pediatrics : JDBP2026
Time to Medication Initiation in School-age Children With ADHD in Developmental-Behavioral Pediatrics.
Article in Journal of developmental and behavioral pediatrics : JDBP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo assess the timing of attention-deficit hyperactivity disorder (ADHD) medication prescriptions in relation to the ADHD diagnostic visit in school-aged children seen in Developmental-Behavioral Pediatrics (DBP) clinics and to investigate which clinical and sociodemographic factors affect the timing of medication prescription.
methodWe retrospectively analyzed electronic health records of children 6 to 12 years old seen between 2016 and 2024 in 6 DBP clinics at Stanford Medicine Children's Health. ADHD cohort included patients with ICD-10 ADHD diagnosis and ≥1 month follow-up. Andersen Health Care Utilization model informed selection of predisposing (age, sex, race/ethnicity), enabling (insurance, clinician type), and need (ADHD subtype, co-occurring conditions) factors. Primary outcome included: time from first ADHD diagnosis to first ADHD medication prescription within 1 year of diagnosis. Cox regression model assessed associations between clinical and sociodemographic factors and study outcome.
resultsOf 823 patients with ADHD, 623 (75.7%) were male; average age at first ADHD diagnosis was 8.2 years (SD = 1.5). Of 823 patients, 484 (58.8%) were prescribed medications within 1 year of diagnosis. The average number of days from ADHD diagnosis to first prescription was 51 days (median = 4). Longer time to medication prescription was associated with Asian race/ethnicity, psychologist clinician, and presence of 1 to 2 co-occurring conditions (most commonly anxiety). Shorter time to prescription was associated with older age, and ADHD combined and hyperactive/impulsive subtypes.
conclusionClinical and sociodemographic factors, including patient race/ethnicity, were associated with timing of medication initiation in school-aged children diagnosed with ADHD in DBP clinics. Future mixed-methods studies are needed to understand factors that influence medication initiation in DBP practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.